Mefloquine reduces the bacterial membrane fluidity of Acinetobacter baumannii and distorts the bacterial membrane when combined with polymyxin B
ABSTRACT Acinetobacter baumannii is a high-priority organism for the development of new antibacterial treatments. We found that the antimalarial medication mefloquine (MFQ) permeabilized the bacterial cell membrane of A. baumannii, decreased membrane fluidity, and caused physical injury to the membr...
Saved in:
| Main Authors: | Nagendran Tharmalingam, Harikrishna Sekar Jayanthan, Jenna Port, Fernanda Cristina Possamai Rossatto, Eleftherios Mylonakis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2025-04-01
|
| Series: | mBio |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/mbio.04016-24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute eosinophilic pneumonia associated with mefloquine prophylaxis: A case report
by: Francesco Virzì, et al.
Published: (2025-01-01) -
Plasmodium ovale Infection After One Year Mefloquine Prophylaxis in A Young Indonesian Soldier: A Case Report
by: Frans Liwang, et al.
Published: (2019-05-01) -
Plasmodium ovale Infection After One Year Mefloquine Prophylaxis in A Young Indonesian Soldier: A Case Report
by: Frans Liwang, et al.
Published: (2019-05-01) -
Case Report: Polymyxin E-associated reversible leukopenia
by: Suxin Wan, et al.
Published: (2025-08-01) -
Metabolic profiling unveils enhanced antibacterial synergy of polymyxin B and teixobactin against multi-drug resistant Acinetobacter baumannii
by: Maytham Hussein, et al.
Published: (2024-11-01)